INTRODUCTION: the main objective of this study is to estimate the prevalence of persistent dysphonia in hospitalised COVID-19 patients.METHODS: data were collected from those COVID-19 patients who, during the months of March to July 2020, were hospitalised in ward or intensive care unit at the University Hospital of Fuenlabrada. Patients with dysphonia prior to SARS-CoV-2 were excluded. Informed consent was obtained orally by a telephone call, as well as clinical and epidemiological data. Patients who reported persistent dysphonia were assessed using the Voice Handicap Index 10, the maximum phonation time, the s/z ratio and a fibrolaryngoscope examination.
No comments:
Post a Comment